Prospective Use of Awake Endoscopy to Direct Inspire Therapy for Obstructive Sleep Apnea

Prospective Use of Awake Endoscopy to Direct Inspire Therapy for Obstructive Sleep Apnea
Not Recruiting
99 years or below
All
1 Location

Brief description of study

The aim of this study is to examine a new method of device configuration for the Inspire upper airway stimulator. First, we will attempt to determine optimal configuration by quantifying changes in upper airway size with different implant configurations using awake nasal endoscopy. The configuration/voltage that results in the greatest increase in upper airway size and is tolerated by the patient will be selected. Patients will then undergo a sleep study so that increased airway size may be correlated with changes in sleep study parameters including AHI and oxygen desaturation index (ODI). Airway size and sleep study parameters using the standard device configuration (+-+)/voltage will be compared to airway size and sleep study parameters using the test, or "optimal," configuration/voltage to determine the usefulness of awake endoscopy in activation of the Inspire device.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Obstructive Sleep Apnea, sleep, OSA, snoring
  • Age: 99 years or below
  • Gender: All
Updated on 01 Aug 2024. Study ID: 828956

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center